ONWARD Medical
ONWARD Medical

ONWARD Medical

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

2015ActiveEindhoven, Netherlands

About

ONWARD Medical is a NeuroTech company focused on developing and commercializing breakthrough technologies that restore movement, function, and independence in people with spinal cord injuries and other movement disabilities. Their proprietary ARC Therapy targets spinal cord stimulation. The company offers both external (ARC-EX® System) and investigational implantable (ARC-IM®) devices. Teams look it up for Biotechnology, Medical Devices, Neurotechnology.

Frequently asked

What does ONWARD Medical do?

ONWARD Medical is a Biotechnology company that offers Hardware. Teams look it up for Medical Devices, Neurotechnology, Healthcare. It is based in Eindhoven, North Brabant, Netherlands and was founded in 2015. Public records show $171M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.

How much funding has ONWARD Medical raised?

ONWARD Medical has raised a total of $171M in funding. The most recent round on record is Private Placement.

Where is ONWARD Medical headquartered?

ONWARD Medical is headquartered in Eindhoven, North Brabant, Netherlands.

When was ONWARD Medical founded?

ONWARD Medical was founded in 2015.

What industry does ONWARD Medical operate in?

ONWARD Medical operates in Biotechnology, Medical Devices, Neurotechnology, Healthcare, Neurotech.

Scores
Measured, not editorial
Ahrefs DR
3/100

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Agent Readiness
50/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Site Speed
54/100

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Add first review